PHARM MANUF/DISTR DIV - FSA

The contract solicitation SPE2D0-25-R-0001, titled PHARM MANUF/DISTR DIV - FSA, is a medical supply procurement under the Department of Defense’s Medical Supply Chain FSG, aimed at securing pharmaceutical manufacturing and distribution services through a long-term commercial item acquisition. The solicitation, posted on September 18, 2025, has a response deadline extending to September 17, 2030, indicating a multi-year framework with a base period of nine to fifteen months and up to ten option periods totaling a potential contract duration of ten years. The NAICS code 424210 identifies the industry as Wholesale Trade of Pharmacies and Drug Stores, emphasizing the commercial nature of the procurement governed under FAR Part 12. The scope centers on a Corporate Exigency Contract (CEC) for medical-surgical supplies, requiring vendors to deliver standardized items identified by National Stock Numbers, maintain compliance with stringent preservation, packaging, labeling, and marking standards, and adhere to Government-Owned Material (GOM) management protocols. Delivery obligations include FOB Destination terms for CONUS shipments, emergency response capability within twenty-four hours, and extended shelf life requirements—six months for domestic and twelve months for overseas deliveries—alongside strict cold chain controls for temperature-sensitive pharmaceuticals documented through DD Form 1502 and compliance with 49 CFR, MIL-STD-129R, ISPM 15, and ASTM D 5445. Contractors must submit proposals electronically via DIBBS in Word, Excel, or PDF formats, including mandatory documentation such as the SF-1449, TGC Evaluation Spreadsheet, representations and certifications, and a GOM drawdown plan. Financial terms include two fixed-base-period fees for inventory management and holding, totaling approximately $84,674.43, with a maximum potential contract value of $14,377,702 over ten years contingent on option exercises and material drawdowns. Evaluation is based on technical compliance and price/fee analysis, with a likely Lowest Price Technically Acceptable (LPTA) award approach, although not explicitly stated. Mandatory clauses cover ethics, conflict of interest, whistleblower protections, cybersecurity (DFARS 252.204-7012, NIST SP 800-171), supply chain security (FAR 52.204-27